The phosphoinositide-3-kinase-like protein kinases ataxia telangiectasia-mutated (ATM) and ataxia telangiectasia-mutated and Rad3-related (ATR) signal in response to chromosomal DNA damage by ...
Berzosertib, an ATR-targeting drug, improves progression-free survival in combination with chemotherapy in patients with high-grade serous ovarian cancer. In its first randomized clinical trial, a ...
The HUDSON trial is explored by Dr Das as she provides an overview of the study and offers key considerations regarding results. Millie Das, MD: The HUDSON trial was a multi-arm umbrella trial for ...
These two images demonstrate synthetic lethality with a non-responsive cell line (right) compared to a responder to ATR +PKMYT1 inhibition (left). As demonstrated by the long strands, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results